Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous T-Cell lymphoma (CTCL). ...
Vous n'êtes pas connecté
Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous T-Cell lymphoma (CTCL). ...
Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous T-Cell lymphoma (CTCL). ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Jun. 17, 2025-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering...
LEXINGTON, Mass.--(BUSINESS WIRE)--Jun. 17, 2025-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering...
By Lakshmy Ramakrishnan Biotechnology is a critical emerging technology holding significant potential in addressing various challenges,...
This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics. The biotech beauty might just be onto a fabled golden bullet for...
This week’s Bulls N’ Bears ASX Runners of the Week is… Amplia Therapeutics. The biotech beauty might just be onto a fabled golden bullet for...
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for leukaemia significantly...
The Federal Government is pumping $1 million into WA biotech Argenica Therapeutics to advance global clinical trials for its potentially life-saving...
The Federal Government is pumping $1 million into WA biotech Argenica Therapeutics to advance global clinical trials for its potentially life-saving...
WEDNESDAY, June 25, 2025 -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast...